Copper influx transporter 1 is required for FGF, PDGF and EGF-induced MAPK signaling
- 1 October 2012
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 84 (8) , 1007-1013
Abstract
No abstract availableKeywords
Funding Information
- NIH (R01 CA152185, CA095298)
- Clayton Medical Research Foundation
- HHP (HL091071, HL107200)
- UCSD Cancer Center Specialized Support Grant (P30 CA23100)
This publication has 38 references indexed in Scilit:
- An All-Atom Model of the Structure of Human Copper Transporter 1Cell Biochemistry and Biophysics, 2012
- A Novel Role for Copper in Ras/Mitogen-Activated Protein Kinase SignalingMolecular and Cellular Biology, 2012
- Proteomic and Functional Genomic Landscape of Receptor Tyrosine Kinase and Ras to Extracellular Signal–Regulated Kinase SignalingScience Signaling, 2011
- Copper Transporters and the Cellular Pharmacology of the Platinum-Containing Cancer DrugsMolecular Pharmacology, 2010
- Regulation of Cisplatin Cytotoxicity by Cu Influx TransportersMetal-Based Drugs, 2010
- The Right to Choose: Multiple Pathways for Activating Copper,Zinc Superoxide DismutaseJournal of Biological Chemistry, 2009
- The FGF family: biology, pathophysiology and therapyNature Reviews Drug Discovery, 2009
- Superoxide dismutase 1 (SOD1) is essential for H 2 O 2 -mediated oxidation and inactivation of phosphatases in growth factor signalingProceedings of the National Academy of Sciences, 2008
- Vertebrate Ctr1 coordinates morphogenesis and progenitor cell fate and regulates embryonic stem cell differentiationProceedings of the National Academy of Sciences, 2007
- The roles of copper transporters in cisplatin resistanceCancer and Metastasis Reviews, 2007